Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?

Core Viewpoint - Shares of Amylyx Pharmaceuticals, Inc. (AMLX) have increased by 26.7% over the past four weeks, closing at $5.36, with a mean price target of $11 indicating a potential upside of 105.2% [1] Price Targets - The average price target consists of five estimates ranging from a low of $8 to a high of $16, with a standard deviation of $3, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 49.3%, while the highest suggests an upside of 198.5% [2] Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has risen by 4.7% over the past month, with two estimates increasing and no negative revisions [12] - AMLX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]